<?xml version="1.0" encoding="UTF-8"?>
<p>Papers written in either English or Chinese describing the use of hepatoprotective agents to treat hepatitis and liver fibrosis were retrieved. Using “chronic hepatitis B, hepatitis B, HBV, liver fibrosis, hepatoprotective, silibinin (silymarin, silybin meglumine), acetylcysteine and ursodeoxycholic bile acid (UDCA)”, the study retrieved papers indexed in the China national knowledge internet (CNKI) (2000 - 2012), Pubmed (19832013), Embase (2000 - 2013) and Cochrane databases (1992 - 2012).</p>
